血清胆汁酸与多囊性肝病的肝体积有关,在用兰胺治疗后会减少
Shosha E I Dekker1, Jörgen Bierau2, Martin Giera3
1Department of Nephrology, Leiden University Medical Center, Leiden, the Netherlands.
European journal of clinical investigation
|December 10, 2023
概括
在具有多囊性肝病 (PLD) 的自体主导性多囊性病 (ADPKD) 中,血清胆酸与肝脏大小相关. 在这些患者中,lanreotide治疗降低了胆酸,但并没有降低肝脏体积.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 腎臟病學 (nephrology) 是一種醫學專業.
- 生物化学 生物化学
背景情况:
- 多囊性肝病 (PLD) 是自身主导性多囊性病 (ADPKD) 的常见并发症.
- 胆酸与PLD的病变产生有关.
- 这项研究调查了有或没有PLD的ADPKD患者的胆酸概况.
研究的目的:
- 为了确定血清胆汁酸水平是否在患有PLD的ADPKD患者中升高.
- 评估lanreotide对PLD中的胆酸水平的影响.
- 探索尿胆酸分泌在PLD中病进展中的作用.
主要方法:
- 血清和尿液胆汁酸的量化使用液体染色学-质谱学.
- 对105名PLD ADPKD患者与52名非PLD ADPKD对照进行了比较.
- 在基线和经过120周的lanreotide或标准护理后分析样本.
主要成果:
- 在肝脏较大的患者中观察到较高的结合胆酸血清基线水平.
- 在PLD患者中,兰胺治疗导致多重血清胆酸的减少.
- 没有发现尿液胆汁酸水平的显著变化或与病进展的相关性.
结论:
- 患有PLD的ADPKD患者的血清胆酸水平与肝脏体积有关.
- 兰胺有效降低血清胆汁酸水平,独立于肝体积的变化.
- 尿液胆汁酸分泌似乎不会导致脏疾病在这个队列的进展.
相关概念视频
Hepatic Drug Excretion: Influencing Factors
132
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
132
Chronic Pancreatitis II: Collaborative Care
92
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
92
Diseases of the Liver and Gallbladder
559
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
559
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
667
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
667


